Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
---|---|
pe ratio | -4.28 |
peg ratio | -0.29 |
price to book ratio | -49.34 |
price to sales ratio | 8.27 |
enterprise value multiple | -4.47 |
price fair value | -49.34 |
profitability ratios | |
---|---|
gross profit margin | 84.29% |
operating profit margin | -169.03% |
pretax profit margin | -171.4% |
net profit margin | -172.75% |
return on assets | -69.68% |
return on equity | -541.59% |
return on capital employed | -109.39% |
liquidity ratio | |
---|---|
current ratio | 1.71 |
quick ratio | 1.68 |
cash ratio | 0.19 |
efficiency ratio | |
---|---|
days of inventory outstanding | 72.61 |
operating cycle | 117.76 |
days of payables outstanding | 264.97 |
cash conversion cycle | -147.20 |
receivables turnover | 8.08 |
payables turnover | 1.38 |
inventory turnover | 5.03 |
debt and solvency ratios | |
---|---|
debt ratio | 0.80 |
debt equity ratio | -13.21 |
long term debt to capitalization | 1.11 |
total debt to capitalization | 1.08 |
interest coverage | -30.74 |
cash flow to debt ratio | -0.68 |
cash flow ratios | |
---|---|
free cash flow per share | -3.57 |
cash per share | 3.57 |
operating cash flow per share | -3.50 |
free cash flow operating cash flow ratio | 1.02 |
cash flow coverage ratios | -0.68 |
short term coverage ratios | -3.68 |
capital expenditure coverage ratio | -48.51 |
Frequently Asked Questions
Travere Therapeutics, Inc. (TVTX) published its most recent earnings results on 31-10-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Travere Therapeutics, Inc. (NASDAQ:TVTX)'s trailing twelve months ROE is -541.59%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Travere Therapeutics, Inc. (TVTX) currently has a ROA of -69.68%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
TVTX reported a profit margin of -172.75% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.71 in the most recent quarter. The quick ratio stood at 1.68, with a Debt/Eq ratio of -13.21.